Notice Information
Notice Title
NP92624 (a-d) Enzyme Replacement Therapy Medicines
Notice Description
Supply of Enzyme Replacement Therapy Medicines to NHS Scotland
Lot Information
Lot 1
Supply of ERT Medicines to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.
Procurement Information
The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000763554
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL508910
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- OJEU - F15 - Voluntary Ex Ante Transparency Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £12,437,853 £10M-£100M
Notice Dates
- Publication Date
- 2 Jul 20241 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 2 Jul 20241 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Contact Name
- Not specified
- Contact Email
- michelle.semple3@nhs.scot
- Contact Phone
- +44 1698794410
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Post Town
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL508910
NP92624 (a-d) Enzyme Replacement Therapy Medicines - Supply of Enzyme Replacement Therapy Medicines to NHS Scotland
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-r6ebe6-0000763554-2024-07-02T00:00:00Z",
"date": "2024-07-02T00:00:00Z",
"ocid": "ocds-r6ebe6-0000763554",
"initiationType": "tender",
"parties": [
{
"id": "org-21",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"address": {
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB"
},
"contactPoint": {
"email": "michelle.semple3@nhs.scot",
"telephone": "+44 1698794410",
"url": "http://"
},
"roles": [
"buyer"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "07",
"description": "Health",
"scheme": "COFOG"
}
],
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics"
}
},
{
"id": "org-24",
"name": "Aventis Pharma Ltd Trading As Sanofi",
"identifier": {
"legalName": "Aventis Pharma Ltd Trading As Sanofi"
},
"address": {
"streetAddress": "410 Thames Valley Park Drive",
"locality": "Reading",
"region": "UK",
"postalCode": "RG6 1PT"
},
"contactPoint": {
"telephone": "+44 1183543118"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
},
{
"id": "org-23",
"name": "Sheriff Court House",
"identifier": {
"legalName": "Sheriff Court House"
},
"address": {
"streetAddress": "27 Chambers Street",
"locality": "Edinburgh",
"postalCode": "EH1 1LB"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525",
"url": "http://"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
"id": "org-21"
},
"tender": {
"id": "ocds-r6ebe6-0000763554",
"title": "NP92624 (a-d) Enzyme Replacement Therapy Medicines",
"description": "Supply of Enzyme Replacement Therapy Medicines to NHS Scotland",
"status": "complete",
"items": [
{
"id": "1",
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.",
"mainProcurementCategory": "goods",
"documents": [
{
"id": "JUL508910",
"documentType": "awardNotice",
"title": "NP92624 (a-d) Enzyme Replacement Therapy Medicines",
"description": "Supply of Enzyme Replacement Therapy Medicines to NHS Scotland",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL508910",
"format": "text/html"
}
],
"lots": [
{
"id": "1",
"description": "Supply of ERT Medicines to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant.",
"status": "complete",
"hasOptions": false
}
],
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"id": "D_PROTECT_RIGHTS",
"description": "The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
}
],
"classification": {
"id": "33600000",
"scheme": "CPV"
},
"reviewDetails": "he notification will incorporate a 'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer. The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
}
},
"awards": [
{
"id": "NP92624 (a-d)",
"suppliers": [
{
"id": "org-24",
"name": "Aventis Pharma Ltd Trading As Sanofi"
}
],
"relatedLots": [
"1"
]
}
],
"contracts": [
{
"id": "NP92624 (a-d)",
"awardID": "NP92624 (a-d)",
"status": "active",
"value": {
"amount": 12437853.03,
"currency": "GBP"
},
"dateSigned": "2024-07-02T00:00:00Z"
}
],
"language": "EN",
"description": "The estimated value of the Framework Agreements referred to in Sections II.1.7 and V.2.4 covers the twenty-four (24) month contract duration and the twelve (12) month extension period of the Framework Agreement. NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at http://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=763554. (SC Ref:763554)",
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000763554"
}
],
"noticetype": "OJEU - F15 - Voluntary Ex Ante Transparency Notice"
}